COVID-19 Vaccination in Young People with Functional Neurological Disorder: A Case-Control Study

Vaccines (Basel). 2022 Nov 28;10(12):2031. doi: 10.3390/vaccines10122031.

Abstract

Background: The emergence of acute-onset functional neurological symptoms, the focus of this study, is one of three stress responses related to immunisation. This case-control study documents the experience of 61 young people with past or current functional neurological disorder (FND) in relation to the COVID-19 vaccination program in Australia.

Methods: Information about the young person's/parent's choice and response pertaining to COVID-19 vaccination was collected as part of routine clinical care or FND research program follow-up.

Results: 61 young people treated for FND (47 females, mean age = 16.22 years) and 46 healthy controls (34 females, mean age = 16.37 years) were included in the study. Vaccination rates were high: 58/61 (95.1%) in the FND group and 45/46 (97.8%) in the control group. In the FND group, 2 young people (2/61, 3.3%) presented with new-onset FND following COVID-19 vaccination; two young people with resolved FND reported an FND relapse (2/36, 5.56%); and two young people with unresolved FND (2/20, 10.0%) reported an FND exacerbation. In the control group no FND symptoms were reported.

Conclusions: Acute-onset FND symptoms following COVID-19 vaccination are uncommon in the general population. In young people prone to FND, COVID-19 vaccination can sometimes trigger new-onset FND, FND relapse, or FND exacerbation.

Keywords: COVID-19 vaccines; SARS-CoV-2 vaccines; adolescents; children; dissociative neurological symptom reactions (DNSRs); functional (dissociative) seizures; functional neurological (conversion) disorder (FND); immunisation stress–related responses (ISRRs); young people.

Grants and funding

This research received no external funding.